Weihua Zhang, Ekman Jenny, Almkvist Asa, Saji Shigehira, Wang Ling, Warner Margaret, Gustafsson Jan-Ake
Departments of Medical Nutrition and Bioscience, Karolinska Institute, Novum, Huddinge, Stockholm S-141 86, Sweden.
Biol Reprod. 2002 Aug;67(2):616-23. doi: 10.1095/biolreprod67.2.616.
Although it is known that, in the uterus, estrogen receptor alpha (ERalpha) is involved in proliferation and progesterone receptor in differentiation, the role of the two other gonadal-hormone receptors expressed in the uterus, androgen receptor (AR) and estrogen receptor beta (ERbeta), remains undefined. In this study, the involvement of AR in 17beta-estradiol (E(2))-induced cellular proliferation in the immature rat uterus was investigated. AR levels were low in the untreated immature uterus, but 24 h after treatment of rats with E(2), there was an increase in the levels of AR and of two androgen-regulated genes, IGF-I and Crisp (cysteine-rich secretory protein). As expected, E(2) induced proliferation of luminal epithelial cells. These actions of E(2) were all blocked by both the antiestrogen tamoxifen and the antiandrogen flutamide. The E(2)-induced AR was found by immunohistochemistry to be localized exclusively in the stroma, mainly in the myometrium, where it colocalized with ERalpha but not with ERbeta. ERbeta, detected with two different ERbeta-specific antibodies, was expressed in both stromal and epithelial cells either alone or together with ERalpha. Treatment with E(2) caused down-regulation of ERalpha and ERbeta in the epithelium. The data suggest that, in E(2)-induced epithelial cell proliferation, ERalpha induces stromal AR and AR amplifies the ERalpha signal by induction of IGF-I. Because AR is never expressed in cells with ERbeta, it is unlikely that ERbeta signaling is involved in this pathway. These results indicate an important role for AR in proliferation of the uterus, where estrogen and androgen do not represent separate pathways but are sequential steps in one pathway.
虽然已知在子宫中,雌激素受体α(ERα)参与增殖过程,而孕激素受体参与分化过程,但子宫中表达的另外两种性腺激素受体,即雄激素受体(AR)和雌激素受体β(ERβ)的作用仍不明确。在本研究中,我们调查了AR在未成熟大鼠子宫中17β-雌二醇(E₂)诱导的细胞增殖中的作用。未处理的未成熟子宫中AR水平较低,但在用E₂处理大鼠24小时后,AR水平以及两种雄激素调节基因IGF-I和Crisp(富含半胱氨酸的分泌蛋白)的水平均有所增加。正如预期的那样,E₂诱导了腔上皮细胞的增殖。E₂的这些作用均被抗雌激素他莫昔芬和抗雄激素氟他胺所阻断。通过免疫组织化学发现,E₂诱导的AR仅定位于基质中,主要在肌层,在那里它与ERα共定位,但不与ERβ共定位。用两种不同的ERβ特异性抗体检测到的ERβ,单独或与ERα一起在基质细胞和上皮细胞中均有表达。用E₂处理导致上皮细胞中ERα和ERβ的下调。数据表明,在E₂诱导的上皮细胞增殖中,ERα诱导基质中的AR,而AR通过诱导IGF-I放大ERα信号。由于AR从未在表达ERβ的细胞中表达,因此ERβ信号不太可能参与此途径。这些结果表明AR在子宫增殖中起重要作用,其中雌激素和雄激素并非代表独立的途径,而是同一途径中的连续步骤。